Compare NAGE & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAGE | HFRO |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | 117 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 290.7M | 344.0M |
| IPO Year | N/A | N/A |
| Metric | NAGE | HFRO |
|---|---|---|
| Price | $3.63 | $6.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 893.0K | 102.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $21.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.71 | $4.94 |
| 52 Week High | $14.66 | $6.83 |
| Indicator | NAGE | HFRO |
|---|---|---|
| Relative Strength Index (RSI) | 28.37 | 53.25 |
| Support Level | N/A | $6.12 |
| Resistance Level | $5.22 | $6.24 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 2.96 | 19.57 |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. It focuses on making investments in real estate securities, including Reits, secured and unsecured fixed-rate loans and corporate bonds, mezzanine securities, structured products, convertible and preferred securities and equities (public and private), and floating rate securities.